Zalicus, Inc. (Nasdaq: ZLCS, Extinct)

Stories of Companies and People Behind - ZLCS Zalicus, Inc. (Nasdaq: ZLCS) is a small capital (around $100M) biopharmaceutical firm. ZLCS has a library of 2000 approved drugs. The company believes that by a technology called “combination High Throughput Screening”, or cHTS, it can make new medicines that have a synergistic function. When two or … Continue reading Zalicus, Inc. (Nasdaq: ZLCS, Extinct)